About Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form
Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form is a rare disease catalogued by Orphanet (ORPHA:315306). It is associated with the CYP21A2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form trials.
Search ClinicalTrials.gov for "Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form" or filter by Orphanet code ORPHA:315306 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form. Updated daily.